Skip to content
2000
Volume 21, Issue 2
  • ISSN: 1871-5273
  • E-ISSN: 1996-3181

Abstract

Ethanolamine is a bioactive molecule found in several cells, including those in the central nervous system (CNS). In the brain, ethanolamine and ethanolamine-related molecules have emerged as prodrug moieties that can promote drug movement across the blood-brain barrier. This improvement in the ability to target drugs to the brain may also mean that in the process, ethanolamine concentrations in the brain are increased enough for ethanolamine to exert its own neurological actions. Ethanolamine and its associated products have various positive functions ranging from cell signaling to molecular storage, and alterations in their levels have been linked to neurodegenerative conditions such as Alzheimer’s disease. This mini-review focuses on the effects of ethanolamine on the CNS and highlights the possible implications of these effects for drug design.

Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/1871527319999201211204645
2022-02-01
2025-11-02
Loading full text...

Full text loading...

/content/journals/cnsnddt/10.2174/1871527319999201211204645
Loading

  • Article Type:
    Review Article
Keyword(s): brain; CNS; Ethanolamine; neuromodulator; phospholipids; prodrug; synaptic
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test